Journal
GLOBAL HEART
Volume 17, Issue 1, Pages -Publisher
UBIQUITY PRESS LTD
DOI: 10.5334/gh.1145
Keywords
Heart Failure; registries; Latin America
Categories
Funding
- Novartis Colombia
Ask authors/readers for more resources
This study used data from the RECOLFACA registry to describe the characteristics and healthcare resource utilization patterns of HF patients in Colombia. The results showed that multiple evidence-based treatments for HF are being widely used in Colombia, but there seems to be room for improvement regarding some interventions for the treatment of patients with HF.
Background:There is a lackofepidemiological data around heart failure (HF) in Latin America; the potential impact description of this disease in middle-income countries is relevant.Objective: This study aimed to describe the characteristics and healthcare resource utilization patterns of HF patients at baseline and six-month follow-up.Methods: This retrospective observational study used data from the RECOLFACA (Registro Colombiano de Falla Cardiaca) registry, which includes data obtained from the examination of clinical records from 2,528 patients in 60 Colombian healthcare institutions. Baseline and six-month follow-up data were evaluated from patients with previous hospital admissions due to HF during the 12 months prior to enrollment.Results: This study analyzed 2,045 patients (42.8% female) with a mean age of 67.71 +/- 13.64 years. The most common etiologies were ischemic (44.4%) and hypertensive heart disease (38.5%). At baseline, 53.4% of patients were classified with NYHA class II, and 73.6% had a reduced left ventricle ejection fraction (LVEF). A year prior to entering the registry, patients were hospitalized an average of 1.4 +/- 1.1 times due to HF. Prescription of evidence-based treatment at baseline included sacubitril/valsartan (10%), ACEI (33%), ARB (41%), beta-blocker (79%), diuretics (68%), and MRA (56%). The average quality oflife score measured using the EQ-5D-3L questionnaire was 78.7 +/- 20.8 at baseline and 82.3 +/- 20.1 at the six-month follow-up. The mortality rate was 6.7%.Conclusions: The use of information from the RECOLFACA registry allowed charac-terization as well as analyses of healthcare resource utilization of patients with heart failure in Colombia. The results of this study show that multiple evidence-based treatments for HF are being widely used in Colombia, but there seems to be room for improvement regarding some interventions for the treatment of patients with HF.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available